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Abstract: Second mitochondria-derived activator of caspase (SMAC) mimetics (SMs) are selective antag-
onists of the inhibitor of apoptosis proteins (IAPs), which activate noncanonical NF-￿B signaling and pro-
mote tumor cell death. Through gene expression analysis, we found that treatment of CD4<jats:sup>+</jats:sup>
T cells with SMs during T helper 17 (T<jats:sub>H</jats:sub>17) cell differentiation disrupted the bal-
ance between two antagonistic transcription factor modules. Moreover, proteomics analysis revealed that
SMs altered the abundance of proteins associated with cell cycle, mitochondrial activity, and the balance
between canonical and noncanonical NF-￿B signaling. Whereas SMs inhibited interleukin-17 (IL-17) pro-
duction and ameliorated T<jats:sub>H</jats:sub>17 cell–driven inflammation, they stimulated IL-22
secretion. Mechanistically, SM-mediated activation of NF-￿B–inducing kinase (NIK) and the transcrip-
tion factors RelB and p52 directly suppressed <jats:italic>Il17a</jats:italic> expression and IL-17A
protein production, as well as the expression of a number of other immune genes. Induction of IL-22
production correlated with the NIK-dependent reduction in cMAF protein abundance and the enhanced
activity of the aryl hydrocarbon receptor. Last, SMs also increased IL-9 and IL-13 production and, un-
der competing conditions, favored the differentiation of naïve CD4<jats:sup>+</jats:sup> T cells into
T<jats:sub>H</jats:sub>2 cells rather than T<jats:sub>H</jats:sub>17 cells. These results demon-
strate that SMs shape the gene expression and protein profiles of T<jats:sub>H</jats:sub>17 cells and
inhibit T<jats:sub>H</jats:sub>17 cell–driven autoimmunity.
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Fig. S1. SMs do not prevent activation and proliferation of TH17 cells. (A) Flow cytometry 
analysis of CD69
+
 TH17 cells 48 hours after differentiation in the presence or absence of SM. 
Data with medians (line) are from 7 experiments. (B) Proliferation of CFSE-labeled splenic CD4 
T cells differentiated under TH17 conditions in the presence of DMSO or SM for 48 hours or 5 
days. Histograms are representative of 2 independent experiments. (C) Flow cytometry analysis 
of cell cycle progression in DMSO or SM treated TH17 cells. Dot plots (left) are representative of 
3 independent experiments. Quantified data (right) are median ± range from all experiments. (D) 
Western blot for cIAP1 and xIAP in lysates of DMSO or SM treated TH17 cells at the indicated 
time points. Blots (left) are representative of 3 independent experiments. Quantified data (right) 
are means ± range of all experiments. *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001 by 
ANOVA with Fisher’s Least Significant Different test. 
  
 
 
Fig. S2. SMs promote NIK-dependent production of TNF in TH17 cells. (A) Flow cytometry 
or qRT-PCR analysis of TNF expression in mouse CD4 T cells that were differentiated under 
TH17 conditions in the presence of DMSO or SM for 48 hours Dot plots are representative of and 
quantified data with medians are from at least 4 independent experiments. (B) Flow cytometry 
analysis of IL-17A abundance in TH17 cells differentiated in the presence of DMSO or SM and 
treated with or without antibody against TNF for 48 hours. Dot plots are representative of 3 
independent experiments. Quantified data are means ± SEM from all experiments. (C) Flow 
cytometry of TNF abundance in mouse splenic CD4 T cells from CD4
CRE
-NIK
F/F 
or littermate 
control (Cre
−
) mice differentiated under TH17 conditions in the presence of DMSO or SM for 48 
hours. Histograms are representative of and quantified mean fluorescent intensity (MFI) data are 
from 5 independent experiments. *P < 0.05, **P < 0.01 by Mann-Whitney (A) or paired t-test 
(C). 
 
  
Fig. S3. SMs do not alter RORγt, IRF4, or BATF protein amounts in TH17 cells. (A and B) 
Flow cytometry analysis of GFP abundance (A) and IL-17A production (B) in CD4 T cells from 
RORγt-GFP transgenic mice differentiated under TH17 or TH0 conditions in the presence of 
DMSO or SM for 48 hours. Flow cytometry plots are representative of and quantified GFP MFI 
data (A) are pooled from 4 independent experiments. (C) Flow cytometry analysis of IRF4 
abundance and IL-17A production in mouse TH17 cells differentiated in the presence of DMSO 
or SM for 48 hours. Dot plots (left) are representative of and quantified data (right) is pooled 
from 4 independent experiments. (D) Western blot for RORγt, IRF4, and BATF in the 
cytoplasmic or nuclear fractions of mouse TH17 cells differentiated in the presence of DMSO or 
SM for 48 hours. Blots are representative of 3 independent experiments. Quantified band 
intensity values are means ± range from all experiments. (E to G) qRT-PCR analysis of Rorc 
(E), Irf4 (F), and Batf (G) mRNA expression in mouse TH17 cells differentiated in the presence 
of DMSO or SM for 48 hours. Data with medians are from 5 experiments. *P < 0.05, **P < 0.01, 
***P < 0.001, and ****P < 0.0001 by Mann-Whitney test (E-G) or ANOVA with Fisher’s Least 
Significant Different test (D).  
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Fig. S4. Single cIAP deficiency cannot recapitulate SM-induced inhibition of TH17 cell 
differentiation. (A) Flow cytometry analysis of IL-17A and IFN-γ production by TH17 cells 
differentiated in the presence of DMSO or the SM LCL161 for 48 hours. Dot plots are 
representative of and the frequency of IL-17A producing cells are from 5 independent 
experiments. (B) Flow cytometry analysis of IL-17A by TH17 cells of the indicated genotype 
differentiated in the presence of DMSO or SM for 48 hours. Data and medians are from at least 3 
independent experiments. *P < 0.05, **P < 0.01 using Mann-Whitney test. 
  
  
 
Fig. S5. Proteomic changes in TH17 cells compared to undifferentiated CD4
+
 T cells. (A to 
E) Mass spectrometry analysis of mouse splenic CD4
+
 T cells cultured under TH17 
differentiation conditions for the indicated times. A set of 3300 proteins formed from all 2-FC 
changes in protein abundance across comparisons and the 100 differentially expressed genes 
were analyzed for functional similarity based on STRING database annotations (A). tSNE 
analysis of proteins whose abundance changed 2-fold or more in both biological replicates at 24 
(B) or 48 (C) hours are colored by average fold change. Volcano plots are of proteins altered in 
abundance in both biological replicates within the metabolism cluster (D) or the transcription and 
ribosome biogenesis cluster (E) at 24h. All data are pooled from 2 biological repeats. 
  
Fig. S6. SMs induce global transcriptional and proteomic changes in TH17 cells. (A) RNA-
microarray analysis of gene expression in mouse CD4
+
 T cells cultured under the indicated 
conditions. Row-scaled heatmap of all Log2-FC changes (left) and Principal component analysis 
(PCA) of all genes expressed (right) are from the analysis of 5 biological replicates. (B) 
Proteomics analysis of protein abundance in mouse CD4
+
 T cells cultured under the indicated 
conditions. Row-scaled heatmap of all Log2-FC changes (left) and PCA of all proteins detected 
(right) are from the analysis of 2 biological replicates. (C to F) The correlation between proteins, 
changed by 2-folds or more when comparing cells treated as indicated, was calculated as a 
function of distance on tSNE plots (Fig.3 and S3). Correlation was calculated by considering the 
protein abundance in paired samples from all experiments. For each measurement a control was 
run by randomly permuting the data.  
 
  
 
Fig. S7. Reduced abundance of metabolic proteins in TH17 compared to undifferentiated 
CD4
+
 T cells. STRING analysis of proteins from the metabolism cluster in Fig. 3A that were 
consistently changed by 2-FC or more in both biological repeats in (A) TH17 versus 
undifferentiated or (B) DMSO versus SM treated TH17 cells at 24 hours. Proteins involved in 
fatty acid metabolism (rectangles), glycolysis/gluconeogensis (diamonds) and TCA = tri-
carboxylic acid cycle (hexagons) were identified by KEGG pathway analysis and STRING 
interactions with confidence score over 0.7 were from the analysis of 2 biological replicates.  
Colors denote average Log2-FC.  
  
Fig. S8. SM increases the abundance of noncanonical NF-κB and cell adhesion proteins in 
TH17 cells. (A and B) STRING analysis of proteins from the TCR & NF-κB cluster in Fig. 3A 
that were consistently changed by 2-FC or more in both biological repeats in DMSO vs SM 
treated TH17 cells (A) or TH17 versus undifferentiated cells (B) at 24 hours. Proteins involved in 
NF-κB signaling (octagons), cell adhesion molecules (CAM; rectangles in A), TCR (rectangles 
in B), or shared between TCR and NF-κB signaling (diamonds in B) were identified by KEGG 
pathway analysis and STRING interactions with confidence score over 0.7 were from the 
analysis of 2 biological replicates. Colors denote average Log2-FC.  
 
 
 
  
Fig. S9. RelB induces the expression of Nfkb2 and reduces the expression of Il17a 
independently of p52. (A and B) qRT-PCR analysis of Il17a (A) and Nfkb2 (B) mRNA 
expression in splenic CD4
+
 T cells transduced with the indicated retroviruses and differentiated 
under TH17 conditions. Data are from 2 (A) or 5 (B) independent experiments. *P < 0.05, **P < 
0.01 using paired t-test.  
 
  
  
 
Fig. S10. SM treatment hinders RORγt binding to Il17a regulatory regions and increases 
the expression of immune checkpoint receptors in TH17 cells. (A and B) ChIP analysis of 
RORγt binding to the Il17a promoter (Il17ap) and CNS5 regions (A) or to the Btla promoter (B) 
in lysates of TH17 cells differentiated in the presence of DMSO or SM. Data are means ± SEM 
from 3 independent experiments. (C to E) qRT-PCR analysis of Btla, Pdcd1, and Lag3 mRNA 
expression in TH17 cells differentiated in the presence of DMSO or SM. Data with means are 
from 7 independent experiments. (F to H) Flow cytometry analysis of BTLA, PD-1, and LAG-3 
abundance on TH17 cells differentiated in the presence of DMSO or SM. Histograms (left) are 
representative of 5 independent experiments. Quantified MFI data are with medians are from all 
experiments. *P < 0.05, **P < 0.01, ***P < 0.001 by student’s t-test (A and B), Mann-Whitney 
test (C to E), or paired t-test (F to H).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S11. SM depletion of cIAP1 but not xIAP activates the noncanonical NF-κB and does 
not alter the nuclear translocation of TH17-associated TFs. (A and C) Full western blots of 
the indicated proteins in lysates of mouse TH17 cells treated with DMSO or SM for the indicated 
times. Blots are representative of at least 3 independent experiments. (B and D) Full western 
blots of the subcellular location of the indicated proteins in lysates of mouse TH17 cells treated 
with DMSO or SM for the indicated times. Blots are representative of at least 3 independent 
experiments.  
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 Data file S1. Differentially expressed genes in DMSO- versus SM-treated TH17 cells. Naïve 
mouse splenic CD4 T cells were treated as in Fig. 2. Data is representative of 5 biological 
repeats. (A) List of all genes RMA normalized and differentially expressed between DMSO and 
SM treated Th17 cells. (B) List of genes with a p-value of <0.05. (C) List of genes with a p-value 
of <0.05 and a Log2-FC ≥1 or ≤ -1. 
 
Data file S2. Differentially expressed proteins in DMSO- versus SM-treated TH17 cells. 
Mouse splenic CD4 T cells were treated as in Fig. 3. Data is representative of 2 biological 
repeats.  (A) List of all proteins differentially expressed between DMSO and SM treated Th17 
cells at 24 hours. (B) List of all proteins differentially expressed between DMSO and SM treated 
Th17 cells at 48 hours. (C) List of all proteins differentially expressed between DMSO treated 
Th17 and undifferentiated cells at 24 hours. (D) List of all proteins differentially expressed 
between DMSO treated Th17 and undifferentiated cells at 48 hours.  
 
Data file S3. Proteins and pathways differentially regulated in TH17 compared to 
undifferentiated cells. Differentially regulated proteins were split into the pathways depicted in 
Fig. 3A. Colored cells with orange or blue indicate proteins that were more or less abundant 
directionally between the two biological repeats by 2-fold or more. 
 
Data file S4. Proteins and pathways differentially regulated in DMSO- and SM-treated 
TH17 cells. Differentially regulated proteins were split into the pathways depicted in Fig. 3A. 
Colored cells with orange or blue indicate proteins that were more or less abundant directionally 
between the two biological repeats by 2-fold or more. 
